| Primary |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
24.0% |
| Suicide Attempt |
15.2% |
| Nasal Congestion |
6.4% |
| Cough |
4.8% |
| Influenza |
4.8% |
| Nasopharyngitis |
4.8% |
| Otitis Media |
2.4% |
| Chills |
1.6% |
| Eustachian Tube Disorder |
1.6% |
| Intentional Overdose |
1.6% |
| Pyrexia |
1.6% |
| Antiallergic Therapy |
0.8% |
| Bronchitis |
0.8% |
| Hypersensitivity |
0.8% |
| Infertility |
0.8% |
| Nasal Disorder |
0.8% |
| Rhinitis Allergic |
0.8% |
| Upper Respiratory Tract Infection |
0.8% |
|
| Death |
21.6% |
| Drug Toxicity |
21.6% |
| Overdose |
9.8% |
| Intentional Overdose |
5.9% |
| Completed Suicide |
3.9% |
| Drug Abuse |
3.9% |
| Drug Eruption |
3.9% |
| Intentional Drug Misuse |
3.9% |
| Toxicity To Various Agents |
3.9% |
| Azoospermia |
2.0% |
| Cardio-respiratory Arrest |
2.0% |
| Cerebral Vasoconstriction |
2.0% |
| Cerebrovascular Accident |
2.0% |
| Confusional State |
2.0% |
| Dizziness |
2.0% |
| Empyema |
2.0% |
| Erectile Dysfunction |
2.0% |
| Hypertensive Crisis |
2.0% |
| Jaundice Neonatal |
2.0% |
| Nausea |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
34.1% |
| Foetal Exposure During Pregnancy |
10.8% |
| Otitis Media |
9.6% |
| Drug Use For Unknown Indication |
8.8% |
| Suicide Attempt |
8.0% |
| Pyrexia |
6.0% |
| Eustachian Tube Disorder |
4.0% |
| Cough |
3.6% |
| Nasopharyngitis |
2.8% |
| Influenza |
2.4% |
| Pain |
2.4% |
| Sinus Headache |
1.6% |
| Back Pain |
1.2% |
| Chills |
0.8% |
| Depression |
0.8% |
| Nasal Congestion |
0.8% |
| Smoking Cessation Therapy |
0.8% |
| Antiallergic Therapy |
0.4% |
| Headache |
0.4% |
| Hypersensitivity |
0.4% |
|
| Death |
18.0% |
| Drug Toxicity |
13.1% |
| Unresponsive To Stimuli |
13.1% |
| Drug Hypersensitivity |
6.6% |
| Intentional Overdose |
6.6% |
| Vomiting |
6.6% |
| Accident |
3.3% |
| Completed Suicide |
3.3% |
| Dizziness |
3.3% |
| Intentional Drug Misuse |
3.3% |
| Pruritus |
3.3% |
| Pyrexia |
3.3% |
| Renal Failure Acute |
3.3% |
| Toxic Skin Eruption |
3.3% |
| Abdominal Pain Upper |
1.6% |
| Anaphylactic Reaction |
1.6% |
| Drug Administration Error |
1.6% |
| Erectile Dysfunction |
1.6% |
| Hepatic Enzyme Increased |
1.6% |
| Hodgkin's Disease |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.0% |
| Asthma |
10.9% |
| Product Used For Unknown Indication |
9.0% |
| Allergic Sinusitis |
7.8% |
| Hypersensitivity |
7.4% |
| Rheumatoid Arthritis |
6.6% |
| Hypertension |
4.3% |
| Depression |
3.9% |
| Convulsion |
3.5% |
| Pain |
3.5% |
| Bone Marrow Conditioning Regimen |
3.1% |
| Chronic Lymphocytic Leukaemia |
3.1% |
| Seasonal Allergy |
2.7% |
| Breast Cancer |
2.3% |
| Crohn's Disease |
2.3% |
| Hot Flush |
2.3% |
| Hyperchlorhydria |
2.3% |
| Osteopenia |
2.3% |
| Vitamin Supplementation |
2.3% |
| Fungal Infection |
2.0% |
|
| Rheumatoid Arthritis |
10.3% |
| Treatment Noncompliance |
10.3% |
| Vision Blurred |
10.3% |
| Thrombotic Thrombocytopenic Purpura |
7.7% |
| Ventricular Extrasystoles |
7.7% |
| Chromaturia |
5.1% |
| Injection Site Pain |
5.1% |
| Insomnia |
5.1% |
| Nausea |
5.1% |
| Sinus Headache |
5.1% |
| Tubulointerstitial Nephritis |
5.1% |
| Agitation |
2.6% |
| Angioedema |
2.6% |
| Blood Potassium Decreased |
2.6% |
| Body Temperature Decreased |
2.6% |
| Breast Mass |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Chest Discomfort |
2.6% |
| Cholelithiasis |
2.6% |
| Cognitive Disorder |
2.6% |
|
| Interacting |
| Blood Pressure Abnormal |
33.3% |
| Sinus Disorder |
33.3% |
| Smoking Cessation Therapy |
33.3% |
|
|
